ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test)

FDA Recall #Z-3304-2024 — Class II — August 21, 2024

Recall #Z-3304-2024 Date: August 21, 2024 Classification: Class II Status: Ongoing

Product Description

ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test)

Reason for Recall

Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.

Recalling Firm

Siemens Healthcare Diagnostics, Inc. — Tarrytown, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

5622 kits

Distribution

Worldwide distribution - US Nationwide.

Code Information

UDI-DI: Material Number 10630886 (100 Test) - 00630414587837; Material Number 10630887 (500 Test) - 00630414587844; Lot Number: 26053337 26054337 26051337 26052337

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated